Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 64 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Nerinetide for acute ischaemic stroke	Nerinetide (NA-1)	Ischaemic stroke	Cardiovascular System	2019	View \| Download
Nicardipine for treating aneurysmal subarachnoid haemorrhage	Nicardipine (NicaPlant; nicardipine hydrochloride)	Aneurysmal subarachnoid haemorrhage	Cardiovascular System	2022	View \| Download
Omecamtiv mecarbil for treating chronic heart failure with reduced ejection fraction	Omecamtiv Mecarbil (AMG 423; CK-1827452)	Heart failure (HF)	Cardiovascular System	2020	View \| Download
PLX-PAD for Critical Limb Ischaemia (with minor tissue loss) in Patients Unsuitable for Revascularisation	PLX-PAD	Critical limb ischaemia (CLI)	Cardiovascular System	2018	View \| Download
Rexmyelocel-T for critical limb ischaemia in patients with diabetes mellitus	REX-001 (Rexmyelocel-T)	Critical limb ischaemia (CLI)	Cardiovascular System	2017	View \| Download
Rituximab (MabThera) maintenance therapy for granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA)	Rituximab (MabThera; Rituxan; RG 105)	Granulomatosis with polyangiitis (GPA) , Microscopic polyangiitis (MPA)	Cardiovascular System	2017	View \| Download
Rivaroxaban (Xarelto) in Combination with Aspirin for Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease	Rivaroxaban (Xarelto; BAY 59-7939)	Cardiovascular disease (CVD)	Cardiovascular System	2017	View \| Download
Rivaroxaban for prevention of cardiovascular events following an episode of decompensated heart failure	Rivaroxaban (Xarelto; BAY 59-7939)	Heart failure (HF)	Cardiovascular System	2018	View \| Download
Rivaroxaban for reducing the risk of major thrombotic vascular events in symptomatic peripheral arterial disease patients with a recent lower extremity revascularisation procedure	Rivaroxaban (Xarelto; BAY 59-7939)	Peripheral arterial disease (PAD)	Cardiovascular System	2019	View \| Download
Sacubitril-valsartan for previously untreated chronic heart failure with reduced ejection fraction in children	Sacubitril-valsartan	Chronic heart failure	Cardiovascular System	2022	View \| Download